N🟁N

ZYTO Corp to Present and Exhibit at The Las Vegas MoneyShow

  //science-technology.news-articles.net/content/2 .. sent-and-exhibit-at-the-las-vegas-moneyshow.html
  Published in Science and Technology on Tuesday, May 11th 2010 at 5:11 GMT by Market Wire
          ^{🞛 This publication is a summary or evaluation of another publication}

LINDON, Utah--([ BUSINESS WIRE ])--ZYTO Corp (Pink Sheets: ZYTC) ([ www.ZYTO.com ]), a bio-communication company specializing in decision support applications which creates an interface between a computer and the human body announced today that it will be presenting and exhibiting at the MoneyShow in Las Vegas, Nevada.

"The Las Vegas MoneyShow is considered one of the largest investor conferences in the United States"

"The Las Vegas MoneyShow is considered one of the largest investor conferences in the United States," explained [ Dr. Vaughn R Cook, CEO of ZYTO Corp. ] "We believe this conference will provide an excellent opportunity to continue building awareness about ZYTO and our proven technological solutions for healthcare professionals,a added Dr. Cook.

The MoneyShow is scheduled for May 10^th through May 13^th and is held at Caesars Palace in Las Vegas, Nevada. For additional information, visit: [ http://www.moneyshow.com/lvms/ ].

About ZYTO Corp

ZYTO Corp was founded by its CEO Dr. Vaughn R Cook, OMD. The company designs and builds computer technology to facilitate decision making about healthcare and wellness options. ZYTO's product mix includes the Pro, Balance and EVOX, sold exclusively by healthcare professionals, and the Compass System built for distributors involved with specific direct sales or network marketing companies.

For more information visit [ www.ZYTO.com ] or contact their Headquarters at 801-224-7199.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports.